US Patent:
20220249443, Aug 11, 2022
Inventors:
- Princeton NJ, US
Jun Li - Pittsburgh PA, US
Jun Shi - San Diego CA, US
Yan Shi - Flourtown PA, US
Shiwei Tao - Hillsborough NJ, US
Hao Zhang - Belle Mead NJ, US
Suresh Dhanusu - Hosur, IN
Kumaravel Selvakumar - Bangalore, IN
Ramesh Babu Reddigunta - Chittoor District, IN
Steven J. Walker - Portage MI, US
Lawrence J. Kennedy - Titusville NJ, US
James R. Corte - Yardley PA, US
Tianan Fang - Newtown PA, US
Sutjano Jusuf - Princeton NJ, US
International Classification:
A61K 31/4192
C07D 401/14
C07D 249/06
A61K 31/27
A61K 31/454
C07D 401/04
Abstract:
The present invention provides compounds of Formula (I):or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.